SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-109229
Filing Date
2016-06-22
Accepted
2016-06-22 09:00:19
Documents
1
Period of Report
2016-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v442679_8k.htm 8-K 26711
  Complete submission text file 0001144204-16-109229.txt   28154
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 161725644
SIC: 2836 Biological Products, (No Diagnostic Substances)